ImmunoCAP ISAC can help you diagnose and manage these patients in several ways:
- Sheds light on the real sensitization profile of multisensitized patients.
- Reveals potential risk of severe food-related reactions.
- Identifies the IgE antibody profile in patients with unsatisfactory response to treatment.
Thanks to the cross-reacting proteins, ImmunoCAP ISAC can give you information on hundreds of allergen sources in addition to the 51 sources the proteins are derived from.
ImmunoCAP ISAC can also reveal unexpected sensitizations or help you rule out allergy by delivering IgE results for a broad spectrum of allergens.
ImmunoCAP ISAC has been shown to provide refined useful information in up to 9 out of 10 multisensitized patients.
As a result, effective and optimized management can be started earlier, which in turn leads to improved patient health and quality of life.